News
Immuno-Oncology
Business & Regulatory
Digital Pathology & AI
Business & Regulatory
Digital Pathology & AI
Molecular Diagnostics
ADCs & Radiopharma
Business & Regulatory
ADCs & Radiopharma
Immuno-Oncology
Business & Regulatory
Business & Regulatory
Immuno-Oncology
ADCs & Radiopharma
Business & Regulatory
Molecular Diagnostics
ADCs & Radiopharma
Business & Regulatory
Oncology
Molecular Diagnostics
Molecular Diagnostics
Immuno-Oncology
Molecular Diagnostics
Immuno-Oncology
ADCs & Radiopharma
ADCs & Radiopharma
Oncology
Hematology
Oncology
Molecular Diagnostics
Molecular Diagnostics
Oncology
Hematology
ADCs & Radiopharma
ADCs & Radiopharma
Digital Pathology & AI
Hematology
Molecular Diagnostics
Oncology
Business & Regulatory
Digital Pathology & AI
Business & Regulatory
Oncology
Immuno-Oncology
Immuno-Oncology
Hematology
News
News from APO|APE News: Cancer care, diagnostic pathology, and precision medicine.
Summit and Akeso Land HARMONi in The Lancet Oncology as Ivonescimab Beats Durvalumab on Survival in a China Biliary Tract Cancer Trial
McKesson Signs Agreement to Acquire Precision Medicine Group for Approximately $2.25 Billion
Ataraxis AI Laboratory Receives CAP Accreditation and a California Clinical Laboratory License, Opening Ataraxis Breast to the State
TwinStrand and the University of Washington Win a $245.2 Million Final Judgment Against Guardant Health, Which Says It Will Appeal
Pathology Foundation Models Plus Semi-Supervised Curation Detect Perineural Invasion in Colon, Prostate and Pancreatic H&E Slides
Pattern Computer and MCW Report Early Results for a Three-Second Saliva Cancer Screen, With 91% Specificity and 44% Sensitivity
European Commission Approves Gilead's Trop-2 ADC Trodelvy Plus Keytruda for First-Line PD-L1-Positive Metastatic Triple-Negative Breast Cancer
Sanofi to Lay Off 229 Blueprint Medicines Workers in Massachusetts, 13 Months After the $9.1 Billion Acquisition
Radiopharm Theranostics Clears Safety Review to Open 180 mCi Cohort in 177Lu-RAD202 HER2 Radioligand Trial
China's NMPA Accepts Leads Biolabs' PD-L1/4-1BB Bispecific Opamtistomig for Review in Neuroendocrine Carcinoma
Ipsen Completes Kartos Therapeutics Acquisition, Adding Phase III MDM2 Inhibitor Navtemadlin in Myelofibrosis
FDA Issues a Third Complete Response Letter for Xspray Pharma's Amorphous Dasatinib Dasynoc
FDA Grants Accelerated Approval to Replimune's Oncolytic Viral Therapy Tudriqev for Anti-PD-1 Refractory Melanoma
Enhertu Improves Progression-Free Survival Over Pembrolizumab Plus Chemotherapy in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
Cytek Prevails on Three of Four Claims in Beckman Coulter Flow Cytometry Patent Trial, Will Contest $56M Award
Craif Raises $33 Million Series D to Bring Its Urine microRNA Cancer Test to the US and File a Pancreatic Cancer Diagnostic in Japan
Biokin's EGFRxHER3 Bispecific ADC Iza-bren Meets PFS Endpoint in China Phase 3 in EGFR-Mutant NSCLC
Alvotech and Lotus Pharmaceutical Sign Semi-Exclusive US Deal for Proposed Durvalumab Biosimilar AVT34, Plus Eight Asian Markets
AbbVie Lines Up 11 WCLC 2026 Presentations Led by an Oral on the PD-1/VEGF Bispecific ABBV-1480
Ultrasensitive ctDNA Turned Positive Before Every Esophageal Recurrence in a 36-Patient Cohort
Liquid Biopsy Caught EGFR C797S in a Patient Progressing on Zipalertinib, a First Outside the Laboratory
A Columbia Group Puts CAR T Cell TNF Upstream of the Macrophages That Drive Cytokine Release Syndrome
Sequencing Batch Effects Moved Copy-Number Fold Changes Across 1,454 Runs at a Seoul Pathology Lab
A Six-Protein Serum Profile Taken Before Infusion Separated Melanoma Patients Who Benefited From Unconditioned TIL Therapy
Five Australian Clinicians Set Out When to Escalate, Pause and Restart 177Lu-PSMA Rather Than Run Six Fixed Cycles
Dimeric FAP Radioligand 177Lu-D7ND Reaches Its First Five Patients After Complete Remissions in Xenografts
West Cancer Center Wins IRB Approval to Enroll in IceCure's ChoICE Breast Cryoablation Study
City of Hope and PeproMene Bio Report BAFF-R CAR T-Cell Therapy in Relapsed B-Cell Lymphomas
Osaka Group Reports Its Accelerator BNCT Experience in About 200 Head and Neck Cancer Cases
A Molecular Tumor Board Reached for a RAF and MEK Clamp in RAF1 S257L Colorectal Cancer Complicated by Gaucher Disease
Pillar Biosciences Panel Validated at LSI Medience for LC-SCRUM-Asia Blood Screening in Lung Cancer
IDEAYA and Genentech to Pair IDE892 With KRAS G12D Inhibitor in MTAP-Deleted Pancreatic Cancer
Hematogenix Flow Cytometry Assay Named in the Label Behind the Accelerated Approval of Zenbexus
FDA Grants Breakthrough Therapy and Fast Track to Norroy's CAIX-Targeted PET Agent 68Ga-NYM096 in Clear Cell Kidney Cancer
Fox Chase Finds Year-Long Treatment-Free Intervals After Enfortumab Vedotin Is Stopped for Toxicity or Response
Guy's and St Thomas' Refined a Rules-Based Decision Support Platform Until It Matched Its Own Breast MDT on 250 Cases
Off-the-Shelf Base-Edited CAR33 T Cells Miss Primary Endpoints in First-in-Human AML Trial
Dual-Center Ultrasound Radiomics Model Predicts Complete Response to Neoadjuvant Chemotherapy in 659 HER2-Positive Breast Cancers
Pembrolizumab After Platinum Linked to Longer Survival in 147 Uterine Carcinosarcoma Patients
Merck Signs On to Sarah Cannon Research Institute Delivery Model for Community-Site Oncology Trials
Inspirata AI Reports Record Second Quarter as Five Academic Cancer Centers Adopt Its Registry Platform
Immatics Replaces the SUPRAME Interim Analysis With a Single Final Readout and Enlarges the Trial for Survival
Cesium-131 Tiles Placed at Resection Held Early Glioblastoma Regrowth to 6% in Phase I GESTALT Trial
FDA Grants Fast Track Designation to Pliant's Oral Integrin Inhibitor PLN-101095 for Checkpoint-Refractory Solid Tumors
CARsgen Books RMB62 Million in First-Half Revenue in Its First Period With Satri-cel on the Market